A TLR-2 ligand peptidoglycan in combination with an in vitro insulin resistance condition (i.e., high glucose with insulin in the culture medium) increased the expression of IP-10 mRNA, indicating the importance of insulin resistance with bacterial signals in NASH progression [30]. The gene discussed is TLR2; the disease is metabolic dysfunction-associated steatohepatitis.